Ask enough successful entrepreneurs how they built their companies and a pattern starts to emerge. Most didn’t begin with a groundbreaking product. They started with a problem they couldn’t ignore.
It’s a lesson billionaire entrepreneur Mark Cuban has talked about for years. The biggest opportunities often come from solving real pain points rather than chasing trends. The entrepreneurs who win are usually the ones who find a problem that frustrates people, costs money or creates inefficiencies and then builds a solution around it.
That philosophy is easy to see in the journey of Andre Esteva, CEO and co-founder of ArteraAI.
Today, Esteva is one of the most recognized names in healthcare AI. He was recently named to TIME Magazine’s 2025 TIME100 Health list, recognizing the world’s most influential people in health. His company, ArteraAI, was named one of TIME’s Best Inventions and selected by the World Economic Forum as a Global Innovator.
But neither started with a quest to build an AI company. It started with a problem.
Looking Beyond The Technology
Artificial intelligence has become one of the hottest topics in business. Every week seems to bring a new AI product, platform or startup promising to revolutionize an industry.
Esteva believes the conversation should start somewhere else.
“AI is the most transformative technology we’ve had in a long time,” he said during a recent interview. “The impact AI has had on the healthcare system, I believe, is as powerful as computers have had on the healthcare system.”
That’s a significant statement coming from someone who has spent much of his career working at the intersection of healthcare and technology. Before launching ArteraAI, Esteva served as Head of Medical AI at Salesforce Research and held engineering roles at Google Research, GE Healthcare and Sandia National Laboratories. His research has been cited more than 25,000 times and helped demonstrate some of the earliest examples of AI performing at levels comparable to physicians in specific medical tasks.
Despite those accomplishments, Esteva saw a larger challenge. Medicine has made remarkable advances over the last several decades, yet physicians still face difficult decisions when determining the best treatment options for individual cancer patients. Two patients with similar diagnoses can respond very differently to the same therapy. That uncertainty became the problem he wanted to solve.
Helping Doctors Personalize Treatment
Unlike many healthcare AI companies focused on diagnosis, ArteraAI focuses on treatment decisions.
“Artera does not diagnose cancer,” Esteva said. “We help personalize therapies.”
It’s an important distinction. The company’s technology helps physicians make more informed treatment decisions by analyzing pathology images and clinical information through artificial intelligence.
The goal isn’t to replace doctors. It’s to give them better information. In healthcare, that matters. Patients want confidence that they’re receiving the right treatment. Physicians want additional insights to support complex decisions. Healthcare systems want better outcomes while managing costs.
According to Esteva, those goals don’t have to compete with each other. “Artera helps everyone,” he said. “Patients, clinicians and the healthcare system.”
That’s one reason ArteraAI has gained traction in the healthcare community. The company’s ArteraAI Prostate Test is currently the only predictive short-term androgen deprivation therapy (ADT) tool recommended by the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for prostate cancer care.
The test is also fully reimbursed under Medicare’s established payment rate, meaning covered Medicare Part B patients have no out-of-pocket costs.
For many startups, building the technology is the hard part. For healthcare companies, achieving clinical adoption and reimbursement can be equally challenging.
A Lesson For Entrepreneurs
One of the biggest mistakes entrepreneurs make is falling in love with a product before fully understanding the problem.
The strongest businesses often do the opposite. They become obsessed with solving a challenge that people face every day.
That challenge might be helping consumers find healthier beverage options. It might be making home loans more efficient. Or it could be helping physicians make more personalized treatment decisions for cancer patients. The industry doesn’t matter nearly as much as the problem. For Esteva, the opportunity wasn’t simply artificial intelligence. It was using AI to address a challenge that affects millions of patients and families. That’s what separates many successful companies from the rest.
Technology changes. Markets evolve. Trends come and go. But businesses that solve meaningful problems have a way of staying relevant. As AI continues to reshape industries, the entrepreneurs who create lasting impact may not be the ones building the most advanced technology. They may be the ones who understand a simple truth that successful founders have known for decades: Find a problem worth solving, and the opportunity often follows.
